ERBB2 and breast cancer: To analyse the molecular mechanisms leading to ERBB2 overexpression in non-breast cancer cell lines, we transfected four LUCIFERASE reporter vectors containing 200 bp–6 kb fragments of the ERBB2 promoter in colon and ovary cell lines.